Drug Shortage Report for DEFEROXAMINE MESYLATE FOR INJECTION

Last updated on 2020-05-29 History
Report ID 105289
Drug Identification Number 02241600
Brand name DEFEROXAMINE MESYLATE FOR INJECTION
Common or Proper name Deferoxamine Mesylate for Injection
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DEFEROXAMINE MESYLATE
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAPERITONEAL INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 500mg GVL
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-02-05
Estimated end date
Actual end date 2020-05-28
Shortage status Resolved
Updated date 2020-05-29
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-05-29 French Compare
v6 2020-05-29 English Compare
v5 2020-04-08 French Compare
v4 2020-04-08 English Compare
v3 2020-02-06 English Compare
v2 2020-02-05 French Compare
v1 2020-02-05 English Compare